HMGB1 and cancer: The existing evidence clearly suggests that high-mobility group box 1 (HMGB1) has different potentials in cancer progressions such as mounting the growth, angiogenesis, migration, invasion, metastasis, and inhibition of apoptosis by affecting different signaling pathways (83, 84).